Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.
Related News
16 August 2026
Houthis launch new attacks on al-Makha and Marib as Yemen conflict escalates
31 August 2026
UAE intercepts drone after US and Iran exchange attacks
27 August 2026
Russia warns it could target UK in response to Kyiv firing British missiles
29 August 2026